ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BYOT Byotrol Plc

0.10
0.00 (0.00%)
20 Sep 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.10 0.05 0.15 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.27 453.89k
Byotrol Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 0.10p. Over the last year, Byotrol shares have traded in a share price range of 0.075p to 1.60p.

Byotrol currently has 453,890,405 shares in issue. The market capitalisation of Byotrol is £453,890.41 . Byotrol has a price to earnings ratio (PE ratio) of -0.27.

Byotrol Share Discussion Threads

Showing 16426 to 16450 of 16450 messages
Chat Pages: 658  657  656  655  654  653  652  651  650  649  648  647  Older
DateSubjectAuthorDiscuss
11/9/2024
15:52
It's all on IMC so you can watch the replay. Note the slide pack has a good backup section that wasn't shown.
1gw
11/9/2024
14:43
been travelling this morning so news from the AGM?tia
football
11/9/2024
10:58
Byotrol AGM about to start, broadcast via Investor Meet Company.
1gw
04/9/2024
11:46
Good-looking catalogue.
1gw
04/9/2024
07:41
Ocean Harvest Technology Group plc

("OHT", the "Company", or the "Group")

Directorate Change



Ocean Harvest Technology Group plc (AIM: OHT), a leading researcher, developer and supplier of proprietary blended seaweed products as functional additives for the global animal feed industry, announces that Ashley Head has been appointed as Executive Chairman with immediate effect. After two years as CEO, Mark Williams will be stepping down from the board today following his resignation.

The Company will look to strengthen the Board and Executive team in the coming weeks.

Ashley Head, Executive Chairman, said:

"Mark has been instrumental in managing the business through our IPO and building out the supply chain to allow the business to scale. He has also addressed key challenges and put a new sales team in place - on behalf of the entire Board, we wish him the best for the future."

loafofbread
03/9/2024
10:53
ByotrolByotrol
2 hours ago


After a long wait, our ANIGENE Professional Chlorine Tablets have officially received DEFRA approval for Tuberculosis Orders, making them the ideal choice for controlling outbreaks of Bovine Tuberculosis and other notifiable diseases.

football
22/8/2024
11:42
Byotrol news below
football
21/8/2024
18:38
Well only the 1 trade todayPlease find below the final order book for the Byotrol auction that closed today at 4pm.In total 2,500,000 shares traded at 0.11 pence per share.
football
19/8/2024
12:12
We have a bid and an offer on the Asset Match auction. The excitement mounts ahead of Wednesday's close.
1gw
16/8/2024
13:02
They had 35 staff, 5 of which were directors who got paid £600K between them!
loafofbread
16/8/2024
11:22
Is there an actual figure in the result that shows how much they have saved by moving of aim?
football
15/8/2024
19:25
A bit of a kitchen sink job but only to be expected.

Good effort getting the results out and holding a AGM.

"With the completion of a fundraising via issue of new ordinary shares in June 2024, the Group is now focused on its key objective to deliver break even as quickly as possible, and then springboard onwards to profitability, helped with the much leaner operational structure achieved through changes made during this 2024 calendar year."

Slight uncertainty on forecast but can't fault the new get up and go attitude from the remaining Byotrol team.

Would it be possible to update your share holder page (March 24) so we know who is involved going forward. (saves an email by putting it here)

loafofbread
15/8/2024
17:59
Annual Report/Results are out, for anyone still interested.
1gw
15/8/2024
17:45
From the Byotrol News section May 24th 2022.

All our products work on Monkeypox.

I would expect them to issue an updated release before the weekend on their various sales platforms.

loafofbread
15/8/2024
08:17
ESE may be a promising broad acting antiviral agent in the treatment of influenza infections.

UK market is approx $1B+ and WW about $40B for cold and flu remedies.

Looking forward to more news on this over the next 6 months.

loafofbread
12/8/2024
23:20
A cure for a shifting antigen?

Now that would be one hell of a trick 🎈

maxk
12/8/2024
23:12
Well well well.

A potential cure for good old fashioned flu and Byotrol own the patent!

Perhaps the £2M was well spent after all.

UTHOR INFORMATION

Daniele F. Mega1, Parul Sharma1, Anja Kipar12, Udo Hetzel2, Chloe Bramwell1, Alan Merritt3, Samuel Wright3, Chris Plummer3, Richard A. Urbanowicz1 and James P. Stewart1*

1Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, United Kingdom

2Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, University of Zurich, Switzerland

3Byotrol Technology Limited, Thornton Science Park, Chester CH2 4NU, UK

loafofbread
12/8/2024
21:54
That's STD's job around here
football
12/8/2024
21:29
You're next footy .. bend over 🦨
maxk
12/8/2024
19:51
This inhibitory effect appears to prevent internalisation of virus and release of progeny virus by targeting neuraminidase activity. Intranasal administration of ESE in mice infected with IAV reduced viral load in lung tissue. ESE may be a promising broad acting antiviral agent in the treatment of influenza infections.



Great to see our new preprint out and first MS from PhD student Dan Mega. Highlights #antiviral use and MOA of a novel phlorotannin rich purified extract from seaweed against #influenza . Great #livuniives #livuninews
Team Science collaboration with partners
@byotrol and @UZH_en @drparul09vet @rich_urbanowicz










so tested on mice what's next

football
07/8/2024
11:35
the 21th will tell but seems they have done more since they came off AMI than they did in the previous 3-4yrs
football
07/8/2024
10:44
Quite an impressive few months of activity on the product front.
loafofbread
06/8/2024
08:54
Further evidence that the company is moving up the animal size scale, having started the Anigene Professional roll-out with a focus on small companion animals they've already targeted zoos/wildlife parks and are now specifically targeting the equine market as well...
1gw
26/7/2024
13:58
would i right in thinking with all the new products coming to market & sales along with the £500k plus we will saving from the AMI delisting next months results could be better than they have been for a few years?
football
26/7/2024
12:30
🙌 Our Managing Director Chris Sedwell and Sales Director Simon Whitfield are in Japan this week, with our valued partners from Good Smile International.

Exhibiting this week at the 39th Annual Meeting of Japanese Society for Infection Prevention and Control held in Kyoto, Good Smile International introduced Byotrol products to the human healthcare market in Japan many years ago and the two companies remain closely connected to this day.

We wish the Good Smile and G Science teams a productive show and look forward to sharing in their success!

loafofbread
Chat Pages: 658  657  656  655  654  653  652  651  650  649  648  647  Older

Your Recent History

Delayed Upgrade Clock